Jones Trading Downgrades Tracon Pharmaceuticals (TCON) to Hold
Tweet
Share
E-mailGet Alerts TCON Hot Sheet
Price: $1.43 --0%
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Jones Trading analyst Soumit Roy downgraded Tracon Pharmaceuticals (NASDAQ: TCON) from Buy to Hold.
For an analyst ratings summary and ratings history on Tracon Pharmaceuticals click here. For more ratings news on Tracon Pharmaceuticals click here.
Shares of Tracon Pharmaceuticals closed at $0.23 yesterday.
You May Also Be Interested In
- JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
- Barclays Downgrades PolyPeptide Group AG (PPGN:SW) to Equalweight
- Benchmark Downgrades Integer Holding (ITGR) to Hold
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
